China Universal Asset Management Company’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Buy |
23,941
+144
| +0.6% | +$2.02K | 0.03% | 278 |
|
|
2025
Q1 | $372K | Sell |
23,797
-1,021
| -4% | -$16K | 0.03% | 270 |
|
|
2024
Q4 | $346K | Buy |
24,818
+2,336
| +10% | +$32.5K | 0.03% | 283 |
|
|
2024
Q3 | $209K | Buy |
22,482
+8,881
| +65% | +$82.6K | 0.02% | 295 |
|
|
2024
Q2 | $126K | Sell |
13,601
-5,013
| -27% | -$46.6K | 0.02% | 284 |
|
|
2024
Q1 | $184K | Buy |
18,614
+7,694
| +70% | +$76.2K | 0.02% | 300 |
|
|
2023
Q4 | $35.3K | Buy |
10,920
+9,330
| +587% | +$30.1K | 0.01% | 396 |
|
|
2023
Q3 | $8.44K | Buy |
1,590
+785
| +98% | +$4.17K | ﹤0.01% | 357 |
|
|
2023
Q2 | $7.67K | Sell |
805
-23
| -3% | -$219 | ﹤0.01% | 335 |
|
|
2023
Q1 | $9.11K | Buy |
828
+209
| +34% | +$2.3K | ﹤0.01% | 302 |
|
|
2022
Q4 | $9.16K | Buy |
619
+56
| +10% | +$829 | ﹤0.01% | 236 |
|
|
2022
Q3 | $11K | Buy |
+563
| New | +$11K | ﹤0.01% | 193 |
|